Loading data
APOGNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 1.4 bn USD | 1.36 bn USD | 1.42 bn USD | 1.44 bn USD | 1.31 bn USD |
| Cost of revenue | 1.09 bn USD | 1 bn USD | 1.05 bn USD | 1.11 bn USD | 1.04 bn USD |
| Gross profit | 319.47 m USD | 359.89 m USD | 367.13 m USD | 335.27 m USD | 274.16 m USD |
| Research and development expense | 11.2 m USD | 29 m USD | 30.3 m USD | 25.5 m USD | 17.3 m USD |
| Selling, general and administrative expense | 235 m USD | 241.78 m USD | 233.3 m USD | 209.49 m USD | 202.64 m USD |
| Operating profit | 84.47 m USD | 118.11 m USD | 133.83 m USD | 125.79 m USD | 22.05 m USD |
| Interest expense | 13.98 m USD | 6.16 m USD | 6.67 m USD | 7.66 m USD | 4.56 m USD |
| Profit before tax | 77.46 m USD | 112.57 m USD | 129.25 m USD | 116.62 m USD | 13.87 m USD |
| Income tax expense | 23.33 m USD | 27.52 m USD | 29.64 m USD | 12.51 m USD | 10.38 m USD |
| Net income (reported basis) | 54.13 m USD | 85.05 m USD | 99.61 m USD | 104.11 m USD | 3.49 m USD |
| Basic earnings per share | 2.54 USD/share | 3.91 USD/share | 4.55 USD/share | 4.73 USD/share | 0.14 USD/share |
| Diluted earnings per share | 2.52 USD/share | 3.89 USD/share | 4.51 USD/share | 4.64 USD/share | 0.14 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.